The Artificial Pancreas Does Its Homework
JDRF-funded researchers across the globe are currently testing artificial pancreas systems. Some clinical trials are inpatient, in which participants stay overnight or for a few days in a hospital or...
View ArticleAccelerating development progress of artificial pancreas systems
Last September, Medtronic announced FDA approval of its MiniMed 530G with Enlite system (sold outside the United States as the Veo since 2009). JDRF applauded the U.S. Food and Drug Administration...
View ArticleInhaled insulin shows value in artificial pancreas study
Last September, results from a JDRF-funded study were announced by Sansum Diabetes Research Institute and JDRF. This study addresses one of the key limitations of early artificial pancreas systems –...
View ArticleClik here to view.
Sleeping Without Fear
Study: Artificial pancreas systems with predictive low-glucose-suspend help reduce overnight hypoglycemia in individuals with type 1 diabetes Bedtime may soon be safer and a lot less anxiety filled for...
View ArticleClik here to view.
Unlocking Type 1 Diabetes Data
JDRF partners with Tidepool on data integration software for better type 1 diabetes management JDRF is partnering with the non-profit organization Tidepool to develop a new data integration tool for...
View ArticleClik here to view.
Advancing a Key Artificial Pancreas Technology
Stable liquid glucagon developed by JDRF partner Xeris evaluated in first clinical study The JDRF Artificial Pancreas (AP) project is focused on accelerating the development of commercially-viable AP...
View ArticleWell-Timed AP Technology Offers Peace of Mind in the UK
A JDRF-funded study at the University of Cambridge showed that an overnight treat-to-range device improved glucose control A recent JDRF-funded study at the University of Cambridge has found that...
View ArticleLeading the Charge: Virginia’s Artificial Pancreas System
The University of Virginia’s Diabetes Assistant system is on the road to automate insulin delivery Researchers at the University of Virginia (UVA) have been working for nearly a decade to turn a novel...
View ArticleClik here to view.
Artificial Pancreas (AP) Technology Take the Stage at the 75th Annual...
Commercialization of hybrid closed-loop systems, dual-hormone AP therapy and pediatric studies were hot topics Watch video of UVA researcher Stacey Anderson, M.D., talking about the DiAs AP system. The...
View ArticleWhite House Honors Tidepool for Its Development of T1D Data Technology
New apps help simplify T1D management Tidepool™—a JDRF-supported nonprofit committed to reducing the burden of type 1 diabetes (T1D)—has received a White House Champion of Change Precision Medicine...
View Article
